Cytokinetics (CYTK) Net Cash Flow (2016 - 2025)
Historic Net Cash Flow for Cytokinetics (CYTK) over the last 15 years, with Q4 2024 value amounting to $47.7 million.
- Cytokinetics' Net Cash Flow rose 25700.27% to $47.7 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$18.4 million, marking a year-over-year decrease of 13976.47%. This contributed to the annual value of -$18.4 million for FY2024, which is 13976.47% down from last year.
- Latest data reveals that Cytokinetics reported Net Cash Flow of $47.7 million as of Q4 2024, which was up 25700.27% from -$143.1 million recorded in Q3 2024.
- In the past 5 years, Cytokinetics' Net Cash Flow ranged from a high of $139.7 million in Q3 2020 and a low of -$143.1 million during Q3 2024
- For the 5-year period, Cytokinetics' Net Cash Flow averaged around $2.9 million, with its median value being $12.0 million (2020).
- Over the last 5 years, Cytokinetics' Net Cash Flow had its largest YoY gain of 254892.85% in 2020, and its largest YoY loss of 358094.35% in 2020.
- Quarter analysis of 5 years shows Cytokinetics' Net Cash Flow stood at -$117.8 million in 2020, then surged by 118.76% to $22.1 million in 2021, then tumbled by 276.69% to -$39.1 million in 2022, then surged by 134.19% to $13.4 million in 2023, then soared by 257.0% to $47.7 million in 2024.
- Its Net Cash Flow was $47.7 million in Q4 2024, compared to -$143.1 million in Q3 2024 and $70.1 million in Q2 2024.